ArticleBMC infectious diseases2025

Incidence of dynamic seroconversion in subjects received the first dose of the SARS-COV-2 vaccine (AstraZeneca, Moderna and Pfizer) in Kinshasa, Democratic Republic of Congo: prospective cohort study.

Eric Kasongo Mukenge et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.